Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.
Ian Reid, J. A. O. Besson, P. V. Best, Peter F. Sharp, H. G. Gemmell, F. W. Smith
Abstract
Open-access reader
Ian Reid, J. A. O. Besson, P. V. Best, Peter F. Sharp, H. G. Gemmell, F. W. Smith
Abstract
Open-access reader
Single photon emission computed tomography (SPECT) imaging of six Huntington's disease patients revealed a striking reduction in regional uptake of cerebral blood flow markers in vivo. Similar changes were found in one patient with "early stage" disease. The findings are compared with parallel magnetic resonance imaging (MRI) studies, and in one case, results of postmortem examination.
OpenAlex reports 34 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Single photon emission computed tomography (SPECT) imaging of six Huntington's disease patients revealed a striking reduction in regional uptake of cerebral blood flow markers in vivo. Similar changes were found in one patient with "early stage" disease. The findings are compared with parallel magnetic resonance imaging (MRI) studies, and in one case, results of postmortem examination.
Key concepts: Single-photon emission computed tomography, Cerebral blood flow, Magnetic resonance imaging, Emission computed tomography, Preclinical imaging, Medicine, Blood flow, Positron emission tomography